Jeffrey T. Walsh, Chief Financial at bluebird bio, Inc. (BLUE), sold 40,000 shares at $176.03 ($7.0M) on 2018-08-30, disclosed to the SEC on 2018-09-04.
Open-market sale of $7.0M BLUE by Chief Financial. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $175.37 | 19,022 | $3.3M | 47.5% |
| 2 | $175.37 | 19,022 | $3.3M | 47.5% |
| 3 | $176.03 | 978 | $172K | 2.5% |
| 4 | $176.03 | 978 | $172K | 2.5% |
| Total | $175.40 avg | 40,000 | $7.0M | 100% |
| Filing → |
| BLUE | SELL | 2019-06-12 | $176K | — | Filing → |
| BLUE | SELL | 2019-05-14 | $198K | — | Filing → |
| BLUE | SELL | 2019-04-12 | $298K | — | Filing → |